Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Facial Feminization Surgery is effective and safe, with minimal complications.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Tufted folliculitis is common in patients with folliculitis decalvans.

Fecal microbiota transplantation effectively reduces symptoms of Feline Hyperesthesia Syndrome in cats.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

FERONIA regulates plant growth, pollen interactions, and sugar signaling.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

A mutant FERONIA gene affects root hair growth at high temperatures.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tinea faciale can be mistaken for lupus due to similar symptoms.